These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 16932271)

  • 41. Radioiodine therapy in hyperthyroid disease: poorer outcome in patients with high 24 hours radioiodine uptake.
    Kristoffersen US; Hesse B; Rasmussen AK; Kjaer A
    Clin Physiol Funct Imaging; 2006 May; 26(3):167-70. PubMed ID: 16640512
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Functional state of the hypothalamo-hypophyseal-thyroid system during 131I treatment of diffuse toxic goiter].
    Lyzhina VD; Ametov AS; Romanenko AM; Vakulenko AD
    Med Radiol (Mosk); 1977 Dec; 22(12):22-6. PubMed ID: 600045
    [No Abstract]   [Full Text] [Related]  

  • 43. [Must the high rate of hypothyroidism after radioiodine therapy for immunogenic hyperthyroidism be considered a part of the cost?].
    Emrich D
    Nuklearmedizin; 1997 Aug; 36(5):5-6. PubMed ID: 9380532
    [No Abstract]   [Full Text] [Related]  

  • 44. The statistic study of radioactive iodine therapy for hyperthyroidism.
    Yoshii H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1981 Jan; 41(1):33-44. PubMed ID: 7232109
    [No Abstract]   [Full Text] [Related]  

  • 45. Incidence of hypothyroidism more than twenty years after therapy in hyperthyroid patients treated with radioactive iodine.
    Ronga G; Esposito M; Baschieri I; Fenzi GF; Martino E; Pinchera A
    J Nucl Med Allied Sci; 1988; 32(4):231-3. PubMed ID: 3230408
    [No Abstract]   [Full Text] [Related]  

  • 46. [Ambulatory treatment of hyperthyroidism with radioiodine].
    Konrády A
    Orv Hetil; 2000 Apr; 141(17):938-9; author reply 939-41. PubMed ID: 10827475
    [No Abstract]   [Full Text] [Related]  

  • 47. [Application of a Markov model to the follow-up of hyperthyroid patients treated with radioactive iodine].
    Barberger-Gateau P; Commenges D; Salamon R; Commenges-Ducos M
    Med Inform (Lond); 1983; 8(2):83-7. PubMed ID: 6865567
    [No Abstract]   [Full Text] [Related]  

  • 48. Theophylline toxicity after iodine 131 treatment for hyperthyroidism.
    Johnson CE; Cohen IA
    Clin Pharm; 1988 Aug; 7(8):620-2. PubMed ID: 3168415
    [No Abstract]   [Full Text] [Related]  

  • 49. Use of a computer-based postal questionnaire for the detection of hypothyroidism following radioiodine therapy for thyrotoxicosis.
    Harrison LC; Buckley JD; Martin FI
    Aust N Z J Med; 1977 Feb; 7(1):27-32. PubMed ID: 326246
    [TBL] [Abstract][Full Text] [Related]  

  • 50. THE METABOLISM OF BIOLOGICALLY IMPORTANT RADIONUCLIDES. V. THE METABOLISM OF RADIOIODINE AND RADIATION DOSAGE IN MAN.
    HALNAN KE
    Br J Radiol; 1964 Feb; 37():101-7. PubMed ID: 14120786
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparison of mortality in hyperthyroidism during periods of treatment with thionamides and after radioiodine.
    Boelaert K; Maisonneuve P; Torlinska B; Franklyn JA
    J Clin Endocrinol Metab; 2013 May; 98(5):1869-82. PubMed ID: 23543662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Iodine-131 therapy for large goiter with hyperthyroidism: clinical observation of 38 cases].
    Zhao YS; Zhao CW; Huang TJ; He B; Yi W
    Di Yi Jun Yi Da Xue Xue Bao; 2004 May; 24(5):591-3. PubMed ID: 15151844
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Questions incidence of posttreatment hypothyroidism in cats.
    Romatowski J
    J Am Vet Med Assoc; 2005 Jul; 227(1):32. PubMed ID: 16013533
    [No Abstract]   [Full Text] [Related]  

  • 54. [Cytologic changes in aspiration biopsy smears from various conditions of the thyroid treated with radioiodine (author's transl)].
    Droese M; Kempken K; Schneider ML; Hör G
    Verh Dtsch Ges Pathol; 1973; 57():336-8. PubMed ID: 4142211
    [No Abstract]   [Full Text] [Related]  

  • 55. [Biological tests for the follow-up of patients treated with radioiodine for hyperthyroidism (author's transl)].
    Tubiana M; Freychet P; Segond G; M'Timet S
    Ann Endocrinol (Paris); 1974; 35(1):40-4. PubMed ID: 4421882
    [No Abstract]   [Full Text] [Related]  

  • 56. [Evaluation of the surgical treatment of hyperthyroidism].
    Baeza A; Becker P; Pineda G
    Rev Med Chil; 1987 Oct; 115(10):936-41. PubMed ID: 3506255
    [No Abstract]   [Full Text] [Related]  

  • 57. [Thyroid carcinoma following I 131 treatment (author's transl)].
    Hartemann P; Leclere J; Valdenaire JC; Vaillant D; Naegelen G; Borelly J
    Ann Endocrinol (Paris); 1974; 35(3):277-8. PubMed ID: 4463792
    [No Abstract]   [Full Text] [Related]  

  • 58. Value and limitations of a highly sensitive immunoradiometric assay for thyrotropin in the study of thyrotroph function.
    Caldwell G; Gow SM; Sweeting VM; Beckett GJ; Seth J; Toft AD
    Clin Chem; 1987 Feb; 33(2 Pt 1):303-5. PubMed ID: 3100103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypothyroidism following 131I therapy for hyperthyroidism in relation to immunologic parameters.
    Lundell G; Holm LE
    Acta Radiol Oncol; 1980; 19(6):449-54. PubMed ID: 6263058
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ablative radioiodine therapy for hyperthyroidism: long term follow up study.
    Kendall-Taylor P; Keir MJ; Ross WM
    Br Med J (Clin Res Ed); 1984 Aug; 289(6441):361-3. PubMed ID: 6432100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.